Four high potential Nova Scotia medical technology companies have been selected to participate in the inaugural cohort of Innovacorp’s MedTech Accelerate Program.
The following companies will each receive up to $50,000 in non-dilutive, non-repayable funding per company and business guidance to address key technical and business milestones. In addition to financial support, program participants will receive one-on-one mentoring, access to incubation space at the Innovacorp Enterprise Centre and sector-specific workshops. Learn more about Innovacorp’s MedTech Accelerate Program.
Axem Neurotechnology – Tony Ingram, Christopher Friesen – Halifax – axemneuro.com
Axem Neurotechnology develops wearable devices to help athletes track and improve their mental training. Their product is a brain-sensing headset that measures the quality of mental practice, allowing athletes to track their progress over time and improve their training using the Axem smartphone app. Axem aims to make information about the brain more accessible through affordable products that enhance human performance.
NovaResp Technologies – Hamed Hanafi – Halifax – novaresp.com
NovaResp develops patient-specific and breath-specific breathing support devices for patients with sleep apnea. The company’s lead product, BreatheAlong, determines the respiratory health of sleep apnea patients and provides personalized breathing support. Using this technology on positive airway pressure (PAP) machines will save patients from strokes and heart attacks and reduce health-care costs.
Audioptics Medical – Rob Adamson, Dan MacDougall – Halifax
Audioptics develops an endoscope for clinical otology (the study of ear anatomy and diseases) that is capable of seeing through the eardrum and into the middle ear. The technology reduces patient exposure to ionizing radiation and provides clinicians with a higher degree of certainty about diagnoses and treatment decisions.
Emagix – Alon Friedman – Halifax
Emagix develops algorithm-driven approaches for diagnosis of retinal and brain vascular injury using images from existing technologies. The company’s solution decreases the time required to capture images, and better identifies and quantifies critical information in the images, allowing early diagnosis and follow-up treatment efficacy. The result is improved patient care and reduced clinical costs.
Halifax, Nova Scotia, November 17, 2017